US5622713A
(en)
*
|
1985-09-17 |
1997-04-22 |
The Regents Of The University Of California |
Method of detoxifying animal suffering from overdose
|
US5252263A
(en)
*
|
1986-06-16 |
1993-10-12 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
IL91664A
(en)
*
|
1988-09-28 |
1993-05-13 |
Yissum Res Dev Co |
Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US5776429A
(en)
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US5733572A
(en)
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
US5228446A
(en)
*
|
1989-12-22 |
1993-07-20 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
US5469854A
(en)
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US5334381A
(en)
*
|
1989-12-22 |
1994-08-02 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US5088499A
(en)
*
|
1989-12-22 |
1992-02-18 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
US6001335A
(en)
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US6146657A
(en)
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US5580575A
(en)
*
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US5705187A
(en)
|
1989-12-22 |
1998-01-06 |
Imarx Pharmaceutical Corp. |
Compositions of lipids and stabilizing materials
|
US5305757A
(en)
*
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
US5123414A
(en)
*
|
1989-12-22 |
1992-06-23 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
US5656211A
(en)
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
US5352435A
(en)
*
|
1989-12-22 |
1994-10-04 |
Unger Evan C |
Ionophore containing liposomes for ultrasound imaging
|
US5230882A
(en)
*
|
1989-12-22 |
1993-07-27 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
US5773024A
(en)
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US20020150539A1
(en)
*
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
WO1992002244A1
(en)
*
|
1990-07-31 |
1992-02-20 |
The Liposome Company, Inc. |
Accumulation of amino acids and peptides into liposomes
|
IS1685B
(is)
*
|
1990-12-11 |
1998-02-24 |
Bracco International B.V. |
Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
|
US20030113369A1
(en)
*
|
1991-01-16 |
2003-06-19 |
Martin Francis J. |
Liposomes with enhanced circulation time and method of treatment
|
JPH04356421A
(ja)
*
|
1991-03-06 |
1992-12-10 |
Green Cross Corp:The |
プロスタグランジン類含有脂肪小体組成物
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US5874062A
(en)
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
DE69113640T2
(de)
*
|
1991-07-03 |
1996-03-07 |
Vestar Inc |
Beladungstechnik zur herstellung arzneistoffhaltiger liposomen.
|
US5325860A
(en)
*
|
1991-11-08 |
1994-07-05 |
Mayo Foundation For Medical Education And Research |
Ultrasonic and interventional catheter and method
|
US20050181021A1
(en)
*
|
1992-02-14 |
2005-08-18 |
Robert Lamb |
Vitamin E phosphate/phosphatidycholine liposomes to protect from or ameliorate cell damage
|
US5665381A
(en)
*
|
1992-02-25 |
1997-09-09 |
Nexstar Pharmaceuticals, Inc. |
Inhibition of aggregation of drug containing particles
|
DE4208527A1
(de)
*
|
1992-03-17 |
1993-09-23 |
Max Planck Gesellschaft |
Liposomen mit negativer ueberschussladung
|
CA2150463A1
(en)
*
|
1992-12-02 |
1994-06-09 |
Donald F. H. Wallach |
Extended duration antacid product
|
DE4244122C1
(de)
*
|
1992-12-24 |
1994-06-01 |
Sanol Arznei Schwarz Gmbh |
Lyophilisierte, wirkstoffhaltige Emulsion zur intravenösen Applikation
|
US5739020A
(en)
*
|
1995-01-10 |
1998-04-14 |
Pope; Edward J. A. |
Encapsulation of animal and microbial cells in an inorganic gel prepared from an organosilicon
|
US7083572B2
(en)
*
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
US5534499A
(en)
*
|
1994-05-19 |
1996-07-09 |
The University Of British Columbia |
Lipophilic drug derivatives for use in liposomes
|
US5736121A
(en)
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
US5741516A
(en)
*
|
1994-06-20 |
1998-04-21 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
US5543152A
(en)
*
|
1994-06-20 |
1996-08-06 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
US5714163A
(en)
*
|
1994-06-27 |
1998-02-03 |
Nexstar Pharmaceuticals, Inc. |
Vinca alkaloid vesicles with enhanced efficacy and tumor targeting properties
|
CA2152765A1
(en)
|
1994-06-30 |
1995-12-31 |
Jeroen Elisabeth-Joseph Knops |
Methods for treating a physiological disorder associated with beta amyloid peptide
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US6387399B1
(en)
|
1994-12-02 |
2002-05-14 |
The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration |
Microencapsulated bioactive agents and method of making
|
US5827531A
(en)
*
|
1994-12-02 |
1998-10-27 |
The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration |
Microcapsules and methods for making
|
US5972379A
(en)
*
|
1995-02-14 |
1999-10-26 |
Sequus Pharmaceuticals, Inc. |
Liposome composition and method for administering a quinolone
|
AU4981896A
(en)
*
|
1995-02-14 |
1996-09-04 |
Sequus Pharmaceuticals, Inc. |
Liposome composition and method for administering liposome-loadable drugs
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
US5800833A
(en)
*
|
1995-02-27 |
1998-09-01 |
University Of British Columbia |
Method for loading lipid vesicles
|
WO1996032930A1
(en)
*
|
1995-04-18 |
1996-10-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Liposome drug-loading method and composition
|
US5997898A
(en)
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US6139819A
(en)
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
US20040208922A1
(en)
*
|
1995-06-07 |
2004-10-21 |
The Regents Of The University Of California |
Method for loading lipid like vesicles with drugs or other chemicals
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
US6033645A
(en)
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
US6447800B2
(en)
|
1996-01-18 |
2002-09-10 |
The University Of British Columbia |
Method of loading preformed liposomes using ethanol
|
DE69736981D1
(de)
|
1996-05-01 |
2007-01-04 |
Imarx Pharmaceutical Corp |
In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
ES2289188T3
(es)
|
1996-09-11 |
2008-02-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Procedimiento para la obtencion de imagenes para el diagnostico usando un agente de contraste y un vasodilatador.
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
US6056973A
(en)
*
|
1996-10-11 |
2000-05-02 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method of preparation
|
US5837282A
(en)
*
|
1996-10-30 |
1998-11-17 |
University Of British Columbia |
Ionophore-mediated liposome loading
|
US5827532A
(en)
*
|
1997-01-31 |
1998-10-27 |
The Reagents Of The University Of California |
Method for loading lipsomes with ionizable phosphorylated hydrophobic compounds, pharmaceutical preparations and a method for administering the preparations
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
US6143276A
(en)
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6537246B1
(en)
*
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
US20050019266A1
(en)
*
|
1997-05-06 |
2005-01-27 |
Unger Evan C. |
Novel targeted compositions for diagnostic and therapeutic use
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
JP4467789B2
(ja)
|
1997-09-18 |
2010-05-26 |
パシラ ファーマシューティカルズ インコーポレーテッド |
持続放出性リポソーム麻酔組成物
|
US6120800A
(en)
*
|
1997-09-25 |
2000-09-19 |
Nexstar Pharmaceuticals, Inc. |
Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties
|
WO1999016425A1
(en)
*
|
1997-09-30 |
1999-04-08 |
The Ohio State University |
Lipid-modified insulin incorporated liposomes for selectively delivering cytotoxic agents to hepatoma cells
|
CA2309548A1
(en)
|
1997-11-14 |
1999-05-27 |
Skyepharma Inc. |
Production of multivesicular liposomes
|
US6787132B1
(en)
|
1997-12-04 |
2004-09-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Combined chemo-immunotherapy with liposomal drugs and cytokines
|
US6123923A
(en)
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
WO1999065467A1
(en)
*
|
1998-06-16 |
1999-12-23 |
See Jackie R |
Method for introducing a chemical agent into the systemic circulation
|
US6277413B1
(en)
|
1998-07-17 |
2001-08-21 |
Skyepharma, Inc. |
Biodegradable compositions for the controlled release of encapsulated substances
|
EP1105098B8
(en)
*
|
1998-08-12 |
2007-10-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Liposomal therapeutic compositions an ammonium sulphate gradient prepared using
|
WO2000023052A1
(en)
*
|
1998-09-16 |
2000-04-27 |
Alza Corporation |
Liposome-entrapped topoisomerase inhibitors
|
US6159931A
(en)
*
|
1998-09-29 |
2000-12-12 |
The Ohio State University |
Lipid-modified insulin incorporated liposomes for selectively delivering cytotoxic agents to hepatoma cells
|
WO2001000173A1
(fr)
*
|
1999-06-24 |
2001-01-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Methode de regulation de la fuite de medicaments encapsules dans des liposomes
|
US7094423B1
(en)
*
|
1999-07-15 |
2006-08-22 |
Inex Pharmaceuticals Corp. |
Methods for preparation of lipid-encapsulated therapeutic agents
|
KR100822684B1
(ko)
*
|
2000-10-04 |
2008-04-17 |
교와 핫꼬 고교 가부시끼가이샤 |
지질막에 의한 미립자의 피복방법
|
CA2430897C
(en)
*
|
2000-12-07 |
2010-11-16 |
Universiteit Utrecht Holding B.V. |
Liposomal composition comprising water-soluble corticosteroids for the treatment of inflammatory disorders
|
CA2442261A1
(en)
*
|
2001-03-26 |
2002-10-03 |
Alza Corporation |
Liposome composition for improved intracellular delivery of a therapeutic agent
|
WO2002080883A2
(en)
*
|
2001-03-27 |
2002-10-17 |
Phares Pharmaceutical Research N.V. |
Method and composition for solubilising a biologically active compound with low water solubility
|
DE10117043A1
(de)
*
|
2001-04-05 |
2002-11-07 |
Gerhard Puetz |
Verfahren zur Eliminierung von potentiell toxischen und/oder schädlichen Stoffen
|
AU2002322024B2
(en)
*
|
2001-05-31 |
2008-05-08 |
Pacira Pharmaceuticals, Inc. |
Encapsulation of nanosuspensions in liposomes and microspheres
|
IL160350A0
(en)
*
|
2001-09-06 |
2004-07-25 |
Yissum Res Dev Co |
A method for preparing liposome formulations with a predefined release profile
|
US20040219201A1
(en)
*
|
2001-12-06 |
2004-11-04 |
Yechezkel Barenholz |
Tempamine compositions and methods of use
|
DE10214983A1
(de)
*
|
2002-04-04 |
2004-04-08 |
TransMIT Gesellschaft für Technologietransfer mbH |
Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
|
US20050152962A1
(en)
*
|
2002-06-12 |
2005-07-14 |
Metselaar Josbert M. |
Composition for treatment of inflammatory disorders
|
EP1393720A1
(en)
*
|
2002-08-27 |
2004-03-03 |
Universiteit Utrecht |
Vesicle-encapsulated corticosteroids for treatment of cancer
|
CA2501647C
(en)
|
2002-10-10 |
2013-06-18 |
Visualsonics Inc. |
High frequency high frame-rate ultrasound imaging system
|
DK2363114T3
(da)
*
|
2002-10-29 |
2015-06-22 |
Insmed Inc |
Opretholdt afgivelse af anti-infektionsmidler
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
WO2004047800A2
(en)
*
|
2002-11-26 |
2004-06-10 |
Gilead Sciences, Inc. |
Method of drug loading in liposomes by gradient
|
WO2004056323A2
(en)
*
|
2002-12-19 |
2004-07-08 |
Alza Corporation |
Method of treating angiogenic tissue growth
|
US8980310B2
(en)
*
|
2002-12-31 |
2015-03-17 |
Bharat Serums and Vaccines, Ltd. |
Non-pegylated long-circulating liposomes
|
DE60330745D1
(de)
*
|
2002-12-31 |
2010-02-11 |
Bharat Serums & Vaccines Ltd |
Nicht-pegylierte lang-zirkulierende Liposome
|
EP1610763A2
(en)
*
|
2003-03-31 |
2006-01-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Stable liposomes or micelles comprising a sphingolipid and a peg-lipopolymer
|
CA2523413A1
(en)
|
2003-04-25 |
2004-11-11 |
The Penn State Research Foundation |
Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
|
JP2007500239A
(ja)
*
|
2003-05-30 |
2007-01-11 |
アルザ・コーポレーシヨン |
薬剤の肺投与の方法
|
CA2526284C
(en)
|
2003-06-25 |
2014-11-18 |
Crucell Holland B.V. |
Binding molecules for the treatment of myeloid cell malignancies
|
WO2005002546A1
(en)
*
|
2003-06-27 |
2005-01-13 |
Smithkline Beecham Corporation |
Stabilized topotecan liposomal composition and methods
|
KR20060123170A
(ko)
*
|
2003-10-24 |
2006-12-01 |
알자 코포레이션 |
지질 입자의 제조방법
|
US20050129753A1
(en)
*
|
2003-11-14 |
2005-06-16 |
Gabizon Alberto A. |
Method for drug loading in liposomes
|
US20050129750A1
(en)
*
|
2003-12-15 |
2005-06-16 |
Yu-Fang Hu |
Process for producing liposome suspension and product containing liposome suspension produced thereby
|
US20050129752A1
(en)
*
|
2003-12-15 |
2005-06-16 |
Tty Biopharm Limited Company |
Use and manufacturing process for liposomal doxorubicin pharmaceutical composition
|
US7842289B2
(en)
*
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
ATE466596T1
(de)
|
2004-01-20 |
2010-05-15 |
Sunnybrook & Womens College |
Hochfrequenz-ultraschall-darstellung mit kontrastmitteln
|
SG169373A1
(en)
|
2004-02-02 |
2011-03-30 |
Engeneic Molecular Delivery Pty Ltd |
Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
|
US8772013B2
(en)
*
|
2004-02-02 |
2014-07-08 |
Engeneic Molecular Delivery Pty Ltd |
Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
|
CN101002107B
(zh)
*
|
2004-03-01 |
2010-06-23 |
阳光溪流女子学院健康科学中心 |
用于心电图触发的回溯彩色血流超声成像的系统和方法
|
JP4833836B2
(ja)
*
|
2004-03-26 |
2011-12-07 |
テルモ株式会社 |
リポソーム製剤
|
AT500143A1
(de)
*
|
2004-04-22 |
2005-11-15 |
Sanochemia Pharmazeutika Ag |
Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung
|
CN103948545B
(zh)
|
2004-05-03 |
2017-10-03 |
益普生生物制药公司 |
用于药物输送的脂质体
|
US8658203B2
(en)
*
|
2004-05-03 |
2014-02-25 |
Merrimack Pharmaceuticals, Inc. |
Liposomes useful for drug delivery to the brain
|
CN1960729B
(zh)
*
|
2004-06-01 |
2012-04-11 |
泰尔茂株式会社 |
伊立替康制剂
|
US20080063702A1
(en)
*
|
2004-09-09 |
2008-03-13 |
Yechezkel Barenholz |
Liposomal Formulations Comprising an Amphipathic Weak Base Like Tempamine for Treatment of Neurodegenerative Conditions
|
US7744920B2
(en)
*
|
2004-09-09 |
2010-06-29 |
Hadasit Medical Research Services & Development Limited |
Use of liposomal glucocorticoids for treating inflammatory states
|
US8349360B2
(en)
|
2004-10-06 |
2013-01-08 |
Bc Cancer Agency |
Liposomes with improved drug retention for treatment of cancer
|
EP1802277B1
(de)
*
|
2004-10-18 |
2010-01-13 |
Polymun Scientific Immunbiologische Forschung GmbH |
Liposomale zusammensetzung einen wirkstoff zur relaxierung glatter muskulatur enthaltend, die herstellung dieser zusammensetzung und deren therapeutische verwendung
|
EP1809254A2
(en)
*
|
2004-10-28 |
2007-07-25 |
Alza Corporation |
Lyophilized liposome formulations and method
|
JP4990786B2
(ja)
*
|
2004-11-05 |
2012-08-01 |
イネックス ファーマシューティカルズ コーポレイション |
薬物リポソーム製剤を安定化するための組成物および方法
|
TW200618820A
(en)
*
|
2004-11-05 |
2006-06-16 |
Alza Corp |
Liposome formulations of boronic acid compounds
|
AU2005303389A1
(en)
*
|
2004-11-15 |
2006-05-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Combination therapy associating preferably a ceramide with a cytotoxic drug
|
WO2006071659A1
(en)
*
|
2004-12-29 |
2006-07-06 |
Trustees Of Boston University |
Delivery of h2 antagonists
|
US20060228395A1
(en)
*
|
2005-04-11 |
2006-10-12 |
Robert Lamb |
Vitamin E phosphate/phosphatidylcholine liposomes to protect from or ameliorate cell damage
|
EP1879583A2
(en)
*
|
2005-05-03 |
2008-01-23 |
Mutual Pharmaceutical Company, Inc. |
Quinine formulations
|
WO2007058895A2
(en)
*
|
2005-11-11 |
2007-05-24 |
Visualsonics Inc. |
Overlay image contrast enhancement
|
PT1962805T
(pt)
|
2005-12-08 |
2016-10-05 |
Insmed Inc |
Composições de anti-infeciosos baseadas em lípidos para tratamento de infeções pulmonares
|
EP1970078A4
(en)
|
2006-01-11 |
2010-11-17 |
Kyowa Hakko Kirin Co Ltd |
COMPOSITION FOR INHIBITING A TARGET GENE IN AN EYEBORN AND REMEDY FOR ACAPIC DISEASE
|
WO2007117550A2
(en)
|
2006-04-06 |
2007-10-18 |
Transave, Inc. |
Methods for coacervation induced liposomal encapsulation and formulations thereof
|
JP5080779B2
(ja)
|
2006-10-25 |
2012-11-21 |
テルモ株式会社 |
リポソーム製剤の製造方法
|
EP1932517A3
(en)
*
|
2006-12-11 |
2008-07-16 |
Universiteit Utrecht Holding B.V. |
Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof
|
WO2008079973A2
(en)
*
|
2006-12-21 |
2008-07-03 |
Centocor, Inc. |
Egfr binding peptides and uses thereof
|
US8278415B2
(en)
|
2006-12-21 |
2012-10-02 |
Centocor, Inc. |
Dimeric high affinity EGFR constructs and uses thereof
|
WO2008079982A2
(en)
|
2006-12-21 |
2008-07-03 |
Centocor, Inc. |
Liposome composition for targeting egfr receptor
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
US20100196455A1
(en)
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
EP3561494B1
(en)
|
2007-12-06 |
2022-03-02 |
Genalyte, Inc. |
METHOD FOR IDENTIFYING A SEQUENCE OF NUCLEOTIDES IN AN UNKNOWN SPECIES OF NUCLEIC ACID 
AND DEVICE FOR CARRYING OUT THE METHOD
|
US9078812B2
(en)
*
|
2007-12-06 |
2015-07-14 |
The Bay Zoltan Foundation For Applied Research |
Particulate drug carriers as desensitizing agents
|
US20090281054A1
(en)
*
|
2008-05-06 |
2009-11-12 |
Venkata Reddy |
Compositions and methods comprising capuramycin analogues
|
WO2009141738A2
(en)
|
2008-05-23 |
2009-11-26 |
The University Of British Columbia |
Modified drugs for use in liposomal nanoparticles
|
US8173621B2
(en)
*
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
JP5681626B2
(ja)
*
|
2008-07-14 |
2015-03-11 |
ポリーペイド リミテッドPolypid Ltd. |
徐放性薬剤キャリア組成物
|
CN105030809A
(zh)
|
2008-08-01 |
2015-11-11 |
协和发酵麒麟株式会社 |
抑制靶基因表达的组合物
|
AU2009302042A1
(en)
|
2008-10-07 |
2010-04-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Liposomal systems comprising sphingomyelin
|
EP3572796B8
(en)
|
2008-10-27 |
2023-01-18 |
Genalyte, Inc. |
Biosensors based on optical probing and sensing
|
US20110223675A1
(en)
*
|
2008-11-20 |
2011-09-15 |
Terumo Kabushiki Kaisha |
Drug release means from liposomes and method for evaluating releasability
|
AR076634A1
(es)
|
2008-11-21 |
2011-06-29 |
Medgenesis Therapeutix Inc |
Composiciones y metodo para tratar desordenes del sistema nervioso central
|
TW201031675A
(en)
|
2008-12-23 |
2010-09-01 |
Pharmasset Inc |
Synthesis of purine nucleosides
|
AU2009329867B2
(en)
|
2008-12-23 |
2015-01-29 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
CN101756902B
(zh)
*
|
2008-12-23 |
2011-10-05 |
上海医药工业研究院 |
一种可乐定多囊脂质体及其制备方法
|
US8551973B2
(en)
*
|
2008-12-23 |
2013-10-08 |
Gilead Pharmasset Llc |
Nucleoside analogs
|
US20100209348A1
(en)
*
|
2009-02-18 |
2010-08-19 |
Arondo Pharma, Inc. |
Methods for determining liposome bioequivalence
|
WO2010113984A1
(ja)
|
2009-03-30 |
2010-10-07 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
リポソーム組成物
|
RU2476216C1
(ru)
*
|
2009-03-30 |
2013-02-27 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Липосомальная композиция
|
US9968583B2
(en)
|
2009-03-30 |
2018-05-15 |
Eisai R & D Management Co., Ltd. |
Method of manufacture of liposome composition
|
TWI576352B
(zh)
*
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
DE102009031274A1
(de)
|
2009-06-30 |
2011-01-13 |
Justus-Liebig-Universität Giessen |
Liposomen zur pulmonalen Applikation
|
WO2011007353A1
(en)
|
2009-07-14 |
2011-01-20 |
Polypid Ltd. |
Sustained-release drug carrier composition
|
US9402812B2
(en)
*
|
2009-09-23 |
2016-08-02 |
Indu JAVERI |
Methods for the preparation of liposomes
|
US10143652B2
(en)
|
2009-09-23 |
2018-12-04 |
Curirx Inc. |
Methods for the preparation of liposomes
|
US20110070294A1
(en)
*
|
2009-09-23 |
2011-03-24 |
Javeri Indu |
Methods for the Administration of Drugs Using Liposomes
|
EP2525778B1
(en)
|
2010-01-19 |
2018-08-01 |
Polypid Ltd. |
Sustained-release nucleic acid matrix compositions
|
US20130052259A1
(en)
|
2010-02-01 |
2013-02-28 |
Yechezkel Barenholz |
Liposomes comprising amphipathic drugs and method for their preparation
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
HUE026235T2
(en)
|
2010-03-31 |
2016-06-28 |
Gilead Pharmasset Llc |
Crystalline (S) -isopropyl 2 - (((S) - (((2R, 3R, 4R, 5R) -5- (2,4-dioxo-3,4-dihydropyrimidin-1 (2H) -IL) - 4-Fluoro-3-hydroxy-4-methyltetrahydrofuran-2-IL) methoxy) (phenoxy) phosphoryl) amino) propanoate
|
TW201136945A
(en)
|
2010-03-31 |
2011-11-01 |
Pharmasset Inc |
Purine nucleoside phosphoramidate
|
EP2374470A1
(fr)
*
|
2010-04-08 |
2011-10-12 |
Beta Innov |
Utilisation thérapeutique de la protéine Beta2m
|
US9408914B2
(en)
|
2010-04-28 |
2016-08-09 |
Kyowa Hakko Kirin Co., Ltd. |
Cationic lipid
|
EP2567952A4
(en)
|
2010-04-28 |
2015-11-25 |
Kyowa Hakko Kirin Co Ltd |
CATIONIC LIPID
|
SG187770A1
(en)
*
|
2010-08-12 |
2013-03-28 |
Univ Nanyang Tech |
A liposomal formulation for ocular drug delivery
|
WO2012061778A2
(en)
|
2010-11-05 |
2012-05-10 |
Genalyte, Inc. |
Optical analyte detection systems and methods of use
|
TW201242974A
(en)
|
2010-11-30 |
2012-11-01 |
Gilead Pharmasset Llc |
Compounds
|
EP2666856A4
(en)
|
2011-01-19 |
2015-01-14 |
Kyowa Hakko Kirin Co Ltd |
COMPOSITION TO INHIBIT TARGET EXPRESSION
|
EP2680820B1
(en)
*
|
2011-03-01 |
2022-11-02 |
2-BBB Medicines B.V. |
Advanced active liposomal loading of poorly water-soluble substances
|
PL226015B1
(pl)
*
|
2011-03-03 |
2017-06-30 |
Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną |
Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
|
CN103370055B
(zh)
|
2011-03-25 |
2015-06-24 |
泰尔茂株式会社 |
缓释性脂质体组合物及其制造方法
|
JP2013095755A
(ja)
|
2011-11-02 |
2013-05-20 |
Kyowa Hakko Kirin Co Ltd |
カチオン性脂質
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
EP2787977A4
(en)
*
|
2011-12-09 |
2015-05-06 |
Univ California |
LIPOSOMAL ACTIVE INVERTING
|
TWI594767B
(zh)
|
2011-12-12 |
2017-08-11 |
協和醱酵麒麟有限公司 |
含有陽離子性脂質之藥物傳遞系統用脂質奈米粒子
|
AU2012353463B2
(en)
|
2011-12-12 |
2017-08-24 |
Kyowa Hakko Kirin Co., Ltd. |
Lipid nanoparticles containing combinations of cationic lipids
|
WO2013114377A1
(en)
|
2012-02-02 |
2013-08-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd |
Stable liposomes for drug delivery
|
EP2825885B1
(en)
|
2012-03-12 |
2021-05-12 |
The Board of Trustees of the University of Illinois |
Optical analyte detection systems with magnetic enhancement
|
JP6402097B2
(ja)
|
2012-05-21 |
2018-10-10 |
インスメッド インコーポレイテッド |
肺感染症を処置するためのシステム
|
AU2013202947B2
(en)
|
2012-06-13 |
2016-06-02 |
Ipsen Biopharm Ltd. |
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
|
US9717724B2
(en)
|
2012-06-13 |
2017-08-01 |
Ipsen Biopharm Ltd. |
Methods for treating pancreatic cancer using combination therapies
|
EP2682106A1
(en)
|
2012-07-03 |
2014-01-08 |
Phares Pharmaceutical Research N.V. |
Method of solubilizing biologically active compounds
|
TW201726599A
(zh)
|
2012-07-06 |
2017-08-01 |
協和醱酵麒麟有限公司 |
陽離子性脂質
|
US9913907B2
(en)
|
2012-07-16 |
2018-03-13 |
Kyowa Hakko Kirin Co., Ltd. |
RNAi pharmaceutical composition for suppressing expression of KRAS gene
|
ES2442450B1
(es)
*
|
2012-08-09 |
2014-12-12 |
Enoc Solutions, S.L. |
Liposomas vacíos como adyuvante de diferentes principios activos, administrados independientemente y en su forma galénica convencional
|
JPWO2014046191A1
(ja)
|
2012-09-21 |
2016-08-18 |
テルモ株式会社 |
局所麻酔薬持続徐放性リポソーム製剤
|
MX2015005992A
(es)
|
2012-11-20 |
2016-03-07 |
Spectrum Pharmaceuticals Inc |
Metodo mejorado para la preparacion de la vincristina liposomal encapsulada para el uso terapeutico.
|
MX2015006681A
(es)
|
2012-11-29 |
2016-04-06 |
Insmed Inc |
Formulaciones de vancomicina estabilizadas.
|
KR20150095809A
(ko)
|
2012-12-12 |
2015-08-21 |
템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 |
암 치료용 조성물 및 방법
|
EP2934303B1
(en)
|
2012-12-19 |
2019-09-04 |
The Research Foundation for the State University of New York |
Compositions and method for light triggered release of materials from nanovesicles
|
FI3922241T3
(fi)
|
2013-02-01 |
2023-11-28 |
Celator Pharmaceuticals Inc |
Niukasti liukoisten lääkkeiden etälataus liposomeihin
|
US10220095B2
(en)
*
|
2013-03-15 |
2019-03-05 |
Taiwan Liposome Company, Ltd |
Controlled drug release liposome compositions and methods thereof
|
US9693958B2
(en)
|
2013-03-15 |
2017-07-04 |
Cureport, Inc. |
Methods and devices for preparation of lipid nanoparticles
|
MX2016002185A
(es)
|
2013-08-27 |
2016-06-06 |
Gilead Pharmasset Llc |
Formulacion combinada de dos compuestos antivirales.
|
WO2015175939A1
(en)
|
2014-05-15 |
2015-11-19 |
Insmed Incorporated |
Methods for treating pulmonary non-tuberculous mycobacterial infections
|
CN106999419A
(zh)
|
2014-08-04 |
2017-08-01 |
佐尼奥尼制药股份有限公司 |
远程装载略微水溶性药物至脂质膜泡
|
WO2016149625A1
(en)
|
2015-03-19 |
2016-09-22 |
University Of Connecticut |
Systems and methods for continuous manufacturing of liposomal drug formulations
|
US11318131B2
(en)
|
2015-05-18 |
2022-05-03 |
Ipsen Biopharm Ltd. |
Nanoliposomal irinotecan for use in treating small cell lung cancer
|
TWI678213B
(zh)
*
|
2015-07-22 |
2019-12-01 |
美商史倍壯製藥公司 |
用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物
|
WO2017031445A1
(en)
|
2015-08-20 |
2017-02-23 |
Merrimack Pharmaceuticals, Inc. |
Combination therapy for cancer treatment
|
CN108495629A
(zh)
|
2015-08-21 |
2018-09-04 |
益普生生物制药有限公司 |
使用包含脂质体伊立替康和奥沙利铂的组合疗法治疗转移性胰腺癌的方法
|
AU2016337370A1
(en)
*
|
2015-10-15 |
2018-05-17 |
Alberto Gabizon |
Liposome composition co-encapsulating doxorubicin and a prodrug of mitomycin C
|
EP3362049A1
(en)
|
2015-10-16 |
2018-08-22 |
Ipsen Biopharm Ltd. |
Stabilizing camptothecin pharmaceutical compositions
|
US10525138B2
(en)
|
2015-12-25 |
2020-01-07 |
Kyowa Hakko Kirin Co., Ltd. |
Compound as cationic lipid
|
CN106220562B
(zh)
*
|
2016-07-29 |
2019-10-01 |
上海璃道医药科技有限公司 |
两种喹啉环类药物的新用途
|
JP2019533684A
(ja)
|
2016-11-02 |
2019-11-21 |
イプセン バイオファーム リミティド |
リポソームイリノテカン、オキサリプラチン、5−フルオロウラシル(およびロイコボリン)を含む併用療法を用いる胃がんの処置
|
CN116763733A
(zh)
|
2017-03-31 |
2023-09-19 |
富士胶片株式会社 |
脂质体组合物及医药组合物
|
SG11202000593TA
(en)
*
|
2017-07-24 |
2020-02-27 |
Pharmosa Biopharm Inc |
Liposome compositions comprising weak acid drugs and uses thereof
|
US10864161B2
(en)
|
2017-10-13 |
2020-12-15 |
American University Of Sharjah |
Systems and methods for targeted breast cancer therapies
|
CN111432801A
(zh)
|
2017-12-21 |
2020-07-17 |
台湾微脂体股份有限公司 |
缓释型曲普坦组合物及通过皮下或类似途径使用其的方法
|
EP3773505A4
(en)
|
2018-03-30 |
2021-12-22 |
Insmed Incorporated |
PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
|
EP3787601A4
(en)
*
|
2018-04-30 |
2022-03-09 |
Purdue Research Foundation |
LIPOSOMAL NANO-FORMULATION OF COMBINATORY ANTIBIOTICS AND USES THEREOF
|
KR20230170124A
(ko)
*
|
2018-05-07 |
2023-12-18 |
파모사 바이오팜 인코포레이티드 |
트레프로스티닐의 제어 방출을 위한 약제학적 조성물
|
EP3811931A4
(en)
*
|
2018-06-20 |
2021-08-04 |
FUJIFILM Corporation |
COMBINATION MEDICINE WITH LIPOSOME COMPOSITION FOR ENCAPSULATING A ACTIVE SUBSTANCE AND IMMUNCHECKPOINT INHIBITOR
|
JP7057434B2
(ja)
|
2018-10-01 |
2022-04-19 |
富士フイルム株式会社 |
薬物を内包するリポソーム組成物およびプラチナ製剤を含む組合せ医薬
|
TWI767149B
(zh)
*
|
2018-10-17 |
2022-06-11 |
台灣微脂體股份有限公司 |
含有免疫調節劑的緩釋藥物組合物及其用途
|
BR112021022182A2
(pt)
|
2019-05-07 |
2021-12-21 |
Univ Do Minho |
Método para produção de lipossomas.
|
US11083705B2
(en)
|
2019-07-26 |
2021-08-10 |
Eisai R&D Management Co., Ltd. |
Pharmaceutical composition for treating tumor
|
US20230080593A1
(en)
|
2020-01-10 |
2023-03-16 |
Pacira Pharmaceuticals, Inc. |
Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions
|
WO2021141959A1
(en)
|
2020-01-10 |
2021-07-15 |
Pacira Pharmaceuticals, Inc. |
Treatment of pain by administration of sustained-release liposomal anesthetic compositions
|
CN111249223B
(zh)
*
|
2020-03-17 |
2022-08-05 |
中国人民解放军联勤保障部队第九〇〇医院 |
一种盐酸普萘洛尔立方液晶凝胶及其制备方法
|
CA3183397A1
(en)
|
2020-06-18 |
2021-12-23 |
Daryl C. Drummond |
Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof
|
AU2021385572A1
(en)
|
2020-11-25 |
2023-06-22 |
Akagera Medicines, Inc. |
Lipid nanoparticles for delivery of nucleic acids, and related methods of use
|
EP4274573A1
(en)
|
2021-01-11 |
2023-11-15 |
Pacira Pharmaceuticals, Inc. |
Treatment of hip pain with sustained-release liposomal anesthetic compositions
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
WO2022197899A2
(en)
|
2021-03-19 |
2022-09-22 |
Pacira Pharmaceuticals, Inc. |
Treatment of pain in pediatric patients by administration of sustained-release liposomal anesthetic compositions
|
WO2023126947A1
(en)
*
|
2022-01-02 |
2023-07-06 |
Moebius Medical Ltd. |
Determination of the trapped volume of a liposome
|
US11918565B1
(en)
|
2022-11-03 |
2024-03-05 |
Pacira Pharmaceuticals, Inc. |
Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions
|